Lentivectors are efficient tools to manipulate the dendritic cell cytoskeleton

Cytoskeleton

Volumn 68, Issue 8, 2011, Pages 434-445

  Metelo, Joao ^a   Ward, Natalie ^a   Thrasher, Adrian J ^a,b   Burns, Siobhan O ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Cytoskeleton rearrangement; Dendritic cells; Lentivirus; Migration; Podosomes

Indexed keywords

LENTIVIRUS VECTOR; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS G GLYCOPROTEIN; VIRUS PROTEIN;

ARTICLE; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; DENDRITIC CELL; GENE TARGETING; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PHENOTYPE; PRESERVATION; PRIORITY JOURNAL; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS;

CYTOSKELETON; DENDRITIC CELLS; GENETIC VECTORS; HUMANS; IMMUNOPHENOTYPING; LENTIVIRUS; TRANSDUCTION, GENETIC;

LENTIVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 80052280246     PISSN: 19493584     EISSN: 19493592     Source Type: Journal    
DOI: 10.1002/cm.20521     Document Type: Article

References (55)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YT, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
2. Banon-Rodriguez I, Monypenny J, Ragazzini C, Franco A, Calle Y, Jones GE, Anton IM. 2011. The cortactin-binding domain of WIP is essential for podosome formation and extracellular matrix degradation by murine dendritic cells. Eur J Cell Biol 90(2-3): 213-223.
3. Bekeredjian-Ding I, Roth SI, Gilles S, Giese T, Ablasser A, Hornung V, Endres S, Hartmann G. 2006. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes J Immunol 176(12): 7438-7446.
4. Blundell MP, Bouma G, Calle Y, Jones GE, Kinnon C, Thrasher AJ. 2008. Improvement of migratory defects in a murine model of Wiskott-Aldrich syndrome gene therapy. Mol Ther 16(5): 836-844.
5. Breckpot K, Dullaers M, Bonehill A, Van Meirvenne S, Heirman C, De Greef C, van der Bruggen P, Thielemans K. 2003. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. J Gene Med 5(8): 654-667.
6. Breckpot K, Corthals J, Heirman C, Bonehill A, Michiels A, Tuyaerts S, De Greef C, Thielemans K. 2004a. Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells. Hum Gene Ther 15(6): 562-573.
7. Breckpot K, Heirman C, Neyns B, Thielemans K. 2004b. Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells. J Gene Med 6(11): 1175-1188.
8. Breckpot K, Emeagi P, Dullaers M, Michiels A, Heirman C, Thielemansi K. 2007. Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors. Hum Gene Ther 18(6): 536-546.
9. Breckpot K, Escors D, Arce F, Lopes L, Karwacz K, Van Lint S, Keyaerts M, Collins M. 2010. HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. J Virol 84(11): 5627-5636.
10. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. 1993. Vesicular stomatitis-virus G glycoprotein pseudotyped retroviral vectors-concentration to very high-titer and efficient gene-transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90(17): 8033-8037.
11. Burns S, Thrasher AJ, Blundell MP, Machesky L, Jones GE. 2001. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 98(4): 1142-1149.
12. Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, Thrasher AJ. 2004. Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton 57(2): 118-132.
13. Cameron P, Pope M, Granelli-Piperno A, Steinman RM. 1996. Dendritic cells and the replication of HIV-1. J Leukoc Biol 59(2): 158-171.
14. Cella M, Sallusto F, Lanzavecchia A. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9(1): 10-16.
15. Chinnasamy N, Chinnasamy D, Toso JF, Lapointe R, Candotti F, Morgan RA, Hwu P. 2000. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors. Hum Gene Ther 11(13): 1901-1909.
16. Chou HC, Anton IM, Holt MR, Curcio C, Lanzardo S, Worth A, Burns S, Thrasher AJ, Jones GE, Calle Y. 2006. WIP regulates the stability and localization of WASP to podosomes in migrating dendritic cells. Curr Biol 16(23): 2337-2344.
17. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C, Grez M, Thrasher AJ. 2002. High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13(7): 803-813.
18. Donello JE, Loeb JE, Hope TJ. 1998. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72(6): 5085-5092.
19. Esslinger C, Romero P, MacDonald HR. 2002. Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors. Hum Gene Ther 13(9): 1091-1100.
20. Esslinger C, Chapatte L, Finke D, Miconnet I, Guillaume P, Levy F, MacDonald HR. 2003. In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. J Clin Invest 111(11): 1673-1681.
21. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. 2000. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25(2): 217-222.
22. Gawden-Bone C, Zhou ZJ, King E, Prescott A, Watts C, Lucocq J. 2010. Dendritic cell podosomes are protrusive and invade the extracellular matrix using metalloproteinase MMP-14. J Cell Sci 123(9): 1427-1437.
23. Gimona M, Buccione R. 2006. Adhesions that mediate invasion. Int J Biochem Cell Biol 38(11): 1875-1892.
24. Gimona M, Buccione R, Courtneidge SA, Linder S. 2008. Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol 20(2): 235-241.
25. Granelli-Piperno A, Delgado E, Finkel V, Paxton W, Steinman RM. 1998. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-Tropic virus to T cells. J Virol 72(4): 2733-2737.
26. Gruber A, Kan-Mitchell J, Kuhen KL, Mukai T, Wong-Staal F. 2000. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 96(4): 1327-1333.
27. Hanawa H, Kelly PF, Nathwani AC, Persons DA, Vandergriff JA, Hargrove P, Vanin EF, Nienhuis AW. 2002. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther 5(3): 242-251.
28. Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5(10): 987-995.
29. Kadowaki N, Ho S, Antonenko S, Malefyt RD, Kastelein RA, Bazan F, Liu YJ. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194(6): 863-869.
30. Kang YB, Stein CS, Heth JA, Sinn PL, Penisten AK, Staber PD, Ratliff KL, Shen H, Barker CK, Martins I, et al. 2002. In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol 76(18): 9378-9388.
31. Lewis PF, Emerman M. 1994. Passage through Mitosis Is Required for Oncoretroviruses but Not for the Human-Immunodeficiency-Virus. J Virol 68(1): 510-516.
32. Lukacs-Kornek V, Engel D, Tacke F, Kurts C. 2008. The role of chemokines and their receptors in dendritic cell biology. Frontiers in Bioscience 13: 2238-2252.
33. MacKenzie TC, Kobinger GP, Kootstra NA, Radu A, Sena-Esteves M, Bouchard S, Wilson JM, Verma IM, Flake AW. 2002. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther 6(3): 349-358.
34. Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y, Yamamoto A, Seya T. 2003. Subcellular localization of toll-like receptor 3 in human dendritic cells. J Immunol 171(6): 3154-3162.
35. Morelli AE, Larregina AT, Ganster RW, Zahorchak AF, Plowey JM, Takayama T, Logar AJ, Robbins PD, Falo LD, Thomson AW. 2000. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappa B-dependent pathway. J Virol 74(20): 9617-9628.
36. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, et al. 2000. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164(11): 5998-6004.
37. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272(5259): 263-267.
38. Pichlmair A, Diebold SS, Gschmeissner S, Takeuchi Y, Ikeda Y, Collins MK, Sousa CRE. 2007. Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via toll-like receptor 9. J Virol 81(2): 539-547.
39. Rouas R, Uch R, Cleuter Y, Jordier F, Bagnis C, Mannoni P, Lewalle P, Martiat P, Van den Broeke A. 2002. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther 9(9): 715-724.
40. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble-antigen by cultured human dendritic cells is maintained by granulocyte-macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor-necrosis-factor-alpha. J Exp Med 179(4): 1109-1118.
41. Sandrin V, Boson B, Salmon P, Gay W, Negre D, Le Grand R, Trono D, Cosset FL. 2002. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34(+) cells derived from human and nonhuman primates. Blood 100(3): 823-832.
42. Schauber CA, Tuerk MJ, Pacheco CD, Escarpe PA, Veres G. 2004. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro. Gene Ther 11(3): 266-275.
43. Schreibelt G, Tel J, Sliepen K, Benitez-Ribas D, Figdor CG, Adema GJ, de Vries IJM. 2010. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol Immunother 59(10): 1573-1582.
44. Schroers R, Sinha I, Segall H, Schmidt-Wolf IGH, Rooney CM, Brenner MK, Sutton RE, Chen SY. 2000. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther 1(2): 171-179.
45. Sharkey CM, North CL, Kuhn RJ, Sanders DA. 2001. Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production. J Virol 75(6): 2653-2659.
46. Sinn PL, Burnight ER, Hickey MA, Blissard GW, McCray PB. 2005. Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol 79(20): 12818-12827.
47. Sozzani S, Allavena P, Vecchi A, Mantovani A. 1999. The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol 66(1): 1-9.
48. Tan PH, Beutelspacher SC, Xue SA, Wang YH, Mitchell P, McAlister JC, Larkin DFP, McClure MO, Stauss HJ, Ritter MA, et al. 2005. Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood 105(10): 3824-3832.
49. Timmerman JM, Levy R. 1999. Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med 50: 507-529.
50. West MA, Prescott AR, Chan KM, Zhou ZJ, Rose-John S, Scheller J, Watts C. 2008. TLR ligand-induced podosome disassembly in dendritic cells is ADAM17 dependent. J Cell Biol 182(5): 993-1005.
51. Yee JK, Miyanohara A, Laporte P, Bouic K, Burns JC, Friedmann T. 1994. A General-method for the generation of high-titer, pantropic retroviral vectors - highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 91(20): 9564-9568.
52. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. 2000. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101(2): 173-185.
53. Zicha D, Dunn GA, Brown AF. 1991. A new direct-viewing chemotaxis chamber. J Cell Sci 99: 769-775.
54. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15(9): 871-875.
55. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72(12): 9873-9880.